$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Domestic price of Ribociclib succinate tablets
2026-02-01 22:25:32
Check Details
Which company's product is Ribociclib?
2026-02-01 22:25:32
Check Details
Is Ribociclib Calilon?
2026-02-01 22:25:32
Check Details
Where to buy Ribociclib
2026-02-01 22:25:32
Check Details
Is Ribociclib a targeted drug?
2026-02-01 22:25:32
Check Details
The difference between Ribociclib and Ribociclib
2026-02-01 22:25:32
Check Details
Do I have to take Ribociclib for three years?
2026-02-01 22:25:32
Check Details
Symptoms of resistance to Ribociclib
2026-02-01 22:25:32
Check Details
Ribociclib resistance lasts for several years
2026-02-01 22:25:32
Check Details
Latest research progress on Ribociclib
2026-02-01 22:25:32
Check Details
Ribociclib’s effects on the heart
2026-02-01 22:25:32
Check Details
Instructions for Relugolix
2026-02-01 22:25:32
Check Details
1
2
...
282
283
284
285
286
287
288
...
10221
10222
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
2
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
3
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
4
Avatrombopag (Doptelet): Oral TPO-RA for Multiple Thrombocytopenia Types
5
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer
6
Gilteritinib (Xospata): Precision Oral Targeted Therapy for FLT3-Mutated AML
7
Macitentan Guide: Dietary Interactions, Contraindications, and Reproductive Safety Protocols
8
Global Update 2026: Selumetinib (KOSELUGO) Expands Indication to Adult NF1-PN and Clinical Management Strategies
9
Lenvatinib Safety Guide: Baseline Assessment & Adverse Reaction Management
10
Donidalorsen (DAWNZERA®) Side Effects and Safety Management Guide
11
Inluriyo (Imlunestrant): Oral SERD for ER+/HER2- Breast Cancer with ESR1 Mutations
12
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies